FindTrial
Sign In

A randomized controlled study on the efficacy and safety of midazolam oral solution in preventing restlessness after adenoidectomy in children—a single center and clinical trial

A randomized controlled study on the efficacy and safety of midazolam oral solution in preventing restlessness after adenoidectomy in children—a single center and clinical trial - A randomized controlled study on the efficacy and safety of midazolam oral solution in preventing restlessness after adenoidectomy in children—a single center and clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071028
Enrollment
Unknown
Registered
2023-04-28
Start date
2023-04-28
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenotonsillar hypertrophy

Interventions

Intervention group:Midazolam oral solution
Control group:Placebo

Sponsors

The Third Affiliated Hospital of the Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 12 Years

Inclusion criteria

Inclusion criteria: The children of the age of 12 years of age were the children of the asa grade ii grade and the patients who had informed the consent of the consent form

Exclusion criteria

Exclusion criteria: Unsigned consent forms, emergency surgery, mental disabilities, neurological diseases with restural symptoms, preoperative combined severe lung disease and heart disease, mental illness, mental illness, more than 50 kilograms, difficult airway, severe liver and kidney disease, and patients with hypoxurazolam oral solution were removed.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative agitation in children with adenoid tonsillectomy;—

Countries

China

Contacts

Public ContactFengjuan Wang

The Third Affiliated Hospital of the Air Force Medical University

149296027@qq.com+86 13689193252

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026